BlackRock Fund Advisors - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 93 filers reported holding REGULUS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$2,723,000
-53.4%
1,210,121
-31.6%
0.00%0.0%
Q3 2016$5,838,000
+20.3%
1,769,086
+5.4%
0.00%0.0%
Q2 2016$4,853,000
-50.8%
1,679,088
+18.0%
0.00%
-50.0%
Q1 2016$9,863,000
-17.6%
1,423,233
+3.7%
0.00%
-33.3%
Q4 2015$11,970,000
+23.6%
1,372,711
-7.3%
0.00%0.0%
Q3 2015$9,687,000
-37.2%
1,481,195
+5.2%
0.00%
-25.0%
Q2 2015$15,435,000
-14.0%
1,408,287
+32.9%
0.00%0.0%
Q1 2015$17,951,000
+12.1%
1,059,704
+6.2%
0.00%0.0%
Q4 2014$16,013,000
+174.9%
998,306
+17.0%
0.00%
+100.0%
Q3 2014$5,826,000
-14.7%
852,959
+0.4%
0.00%0.0%
Q2 2014$6,828,000
-7.3%
849,286
+4.1%
0.00%0.0%
Q1 2014$7,362,000
+31.5%
816,211
+7.7%
0.00%0.0%
Q4 2013$5,598,000
+104.7%
757,577
+161.2%
0.00%
+100.0%
Q3 2013$2,735,000
+24.3%
290,067
+29.3%
0.00%0.0%
Q2 2013$2,201,000224,3160.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
RA Capital Management 4,039,823$26,420,0003.79%
Foresite Capital Management II, LLC 1,750,269$11,447,0003.48%
ARGONAUT CAPITAL MANAGEMENT CORP 75,000$491,0001.65%
Abingworth LLP 327,350$2,138,0001.25%
Trellus Management Company, LLC 100,000$654,0000.96%
Cormorant Asset Management, LP 896,522$5,863,0000.94%
DAFNA Capital Management LLC 90,000$589,0000.58%
ORACLE INVESTMENT MANAGEMENT INC 749,064$4,898,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
View complete list of REGULUS THERAPEUTICS INC shareholders